Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR.
Aaron YarlasAndrew LovleyKristen McCauslandDuncan BrownMontserrat Vera-LlonchIsabel ConceiçãoChafic KaramSami KhellaLaura ObiciMárcia Waddington-CruzPublished in: Neurology and therapy (2021)
ClinicalTrials.gov Identifiers NCT01737398 for NEURO-TTR study; NCT02175004 for OLE study INFOGRAPHIC.